Your browser doesn't support javascript.
loading
Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma.
Grande, Enrique; Bamias, Aristotelis; Galsky, Matthew D; Kikuchi, Eiji; Davis, Ian D; Arranz, José Ángel; Rezazadeh Kalebasty, Arash; Garcia Del Muro, Xavier; Park, Se Hoon; De Giorgi, Ugo; Alekseev, Boris; Mencinger, Marina; Izumi, Kouji; Puente, Javier; Li, Jian-Ri; Bernhard, Sandrine; Nicholas, Alan; Telliez, Julie; De Santis, Maria.
Afiliación
  • Grande E; Hospital Ramon y Cajal, Madrid, Spain.
  • Bamias A; National & Kapodistrian University of Athens, Athens, Greece.
  • Galsky MD; Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, New York, NY, USA.
  • Kikuchi E; Keio University Hospital, Tokyo, Japan.
  • Davis ID; Monash University, Melbourne, Australia.
  • Arranz JÁ; Eastern Health Clinical School, Melbourne, Australia.
  • Rezazadeh Kalebasty A; Gregorio Maranon Hospital, Madrid, Spain.
  • Garcia Del Muro X; Norton Cancer Institute, Louisville, KY, USA.
  • Park SH; Catalan Institute of Oncology, IDIBELL, University of Barcelona, Barcelona, Spain.
  • De Giorgi U; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Alekseev B; IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy.
  • Mencinger M; Research Oncology Institute, Tomsk, Russia.
  • Izumi K; Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Puente J; Kanazawa University Hospital, Kanazawa, Japan.
  • Li JR; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, CIBERONC, Madrid, Spain.
  • Bernhard S; Taichung Veterans General Hospital, Taichung, Taiwan.
  • Nicholas A; Roche Products Limited, Welwyn Garden City, UK.
  • Telliez J; Genentech Inc., South San Francisco, CA, USA.
  • De Santis M; F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Eur Urol Open Sci ; 58: 28-36, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37954037
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Eur Urol Open Sci Año: 2023 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Eur Urol Open Sci Año: 2023 Tipo del documento: Article País de afiliación: España